... have effectively circulated in people in the past, there is a need for additional research to characterize currently circulating H2 influenza viruses. There is also a need to stockpile vaccines that are effective against both historical H2 laboratory isolates and H2 viruses currently circulating...

... and the use of OMVs as vaccine delivery vehicles and other potential applications. Correspondence: Régis Stentz ( [email protected] ) or Simon R. Carding ( [email protected] ) 13 5 2018 23 7 2018 24 7 2018 The production and release of membrane vesicles from...

...Joel D. Allen; Rogier W. Sanders; Katie J. Doores; Max Crispin The extensive post-translational modifications of the envelope spikes of the human immunodeficiency virus (HIV) present considerable challenges and opportunities for HIV vaccine design. These oligomeric glycoproteins typically have over...

...C. Rhyner; T. Kündig; C.A. Akdis; R. Crameri The worldwide increase in the incidence of allergic diseases and the limited efficacy of current vaccines require the development of new efficient vaccination strategies. Based on PTD (protein transduction domain) technology, we have engineered MAT...

...C.A.L.S. Colaco; C.R. Bailey; J. Keeble; K.B. Walker The need for an effective TB (tuberculosis) vaccine remains acute, with tuberculosis still one of the major killers worldwide and 3 million new infections annually. We report here on the immune responses elicited by HspCs (heat-shock protein...

.... 1 To whom correspondence should be addressed, at the Department of Neurology, New York University Medical Center (e-mail [email protected] ) 10 4 2002 © 2002 Biochemical Society 2002 amyloid-β conformation treatment vaccine AD, Alzheimer's disease Aβ...

... in Leishmania . To whom correspondence should be addressed (e-mail [email protected] ) 30 6 2000 © 2000 Biochemical Society 2000 genome sequencing regulatable promoter serodiagnosis transcription vaccine Chr, chromosome LD1, Leishmania DNA 1 LmjF, Leishmania major Friedlin...